原发性皮肤淋巴瘤放疗的现代方法：来自DEGRO皮肤肿瘤学工作组的见解和建议。

IF 2.5 3区医学 Q3 ONCOLOGY

Strahlentherapie und Onkologie Pub Date : 2025-09-09 DOI:10.1007/s00066-025-02453-5

Khaled Elsayad, Dora Correia, Ulrike Theiß, Andrea Baehr, Angela Besserer, Oliver Micke, Burkhard Greve, Cora Waldstein, Stefanie Corradini, Daniel Habermehl, Laila König, Kathrin Hering, Sebastian Adeberg, Hans Theodor Eich

{"title":"原发性皮肤淋巴瘤放疗的现代方法：来自DEGRO皮肤肿瘤学工作组的见解和建议。","authors":"Khaled Elsayad, Dora Correia, Ulrike Theiß, Andrea Baehr, Angela Besserer, Oliver Micke, Burkhard Greve, Cora Waldstein, Stefanie Corradini, Daniel Habermehl, Laila König, Kathrin Hering, Sebastian Adeberg, Hans Theodor Eich","doi":"10.1007/s00066-025-02453-5","DOIUrl":null,"url":null,"abstract":"The growing use of reduced-dose radiotherapy in patients with primary cutaneous lymphoma is a promising development. Nevertheless, the absence of controlled clinical trials to ascertain standardized doses for each specific type constitutes a significant impediment to the advancement of this field. This expert opinion strongly advocates for advancements in radiation oncology practice that address the unique complexities of primary cutaneous lymphoma. By refining our methodologies, we can optimize patient care and outcomes in this dynamic field.","PeriodicalId":21998,"journal":{"name":"Strahlentherapie und Onkologie","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Modern approaches to radiotherapy in primary cutaneous lymphomas: insights and recommendations from the DEGRO dermato-oncology working group.\",\"authors\":\"Khaled Elsayad, Dora Correia, Ulrike Theiß, Andrea Baehr, Angela Besserer, Oliver Micke, Burkhard Greve, Cora Waldstein, Stefanie Corradini, Daniel Habermehl, Laila König, Kathrin Hering, Sebastian Adeberg, Hans Theodor Eich\",\"doi\":\"10.1007/s00066-025-02453-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The growing use of reduced-dose radiotherapy in patients with primary cutaneous lymphoma is a promising development. Nevertheless, the absence of controlled clinical trials to ascertain standardized doses for each specific type constitutes a significant impediment to the advancement of this field. This expert opinion strongly advocates for advancements in radiation oncology practice that address the unique complexities of primary cutaneous lymphoma. By refining our methodologies, we can optimize patient care and outcomes in this dynamic field.\",\"PeriodicalId\":21998,\"journal\":{\"name\":\"Strahlentherapie und Onkologie\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Strahlentherapie und Onkologie\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00066-025-02453-5\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Strahlentherapie und Onkologie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00066-025-02453-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

原发性皮肤淋巴瘤患者越来越多地使用低剂量放疗是一个有希望的发展。然而，缺乏对照临床试验来确定每种特定类型的标准化剂量，这对这一领域的发展构成了重大障碍。这一专家意见强烈主张在放射肿瘤学实践的进步，以解决原发性皮肤淋巴瘤的独特复杂性。通过改进我们的方法，我们可以在这个动态领域优化患者护理和结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Modern approaches to radiotherapy in primary cutaneous lymphomas: insights and recommendations from the DEGRO dermato-oncology working group.

The growing use of reduced-dose radiotherapy in patients with primary cutaneous lymphoma is a promising development. Nevertheless, the absence of controlled clinical trials to ascertain standardized doses for each specific type constitutes a significant impediment to the advancement of this field. This expert opinion strongly advocates for advancements in radiation oncology practice that address the unique complexities of primary cutaneous lymphoma. By refining our methodologies, we can optimize patient care and outcomes in this dynamic field.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Strahlentherapie und Onkologie 医学-核医学

CiteScore

5.70

自引率

12.90%

发文量

141

审稿时长

3-8 weeks

期刊介绍： Strahlentherapie und Onkologie, published monthly, is a scientific journal that covers all aspects of oncology with focus on radiooncology, radiation biology and radiation physics. The articles are not only of interest to radiooncologists but to all physicians interested in oncology, to radiation biologists and radiation physicists. The journal publishes original articles, review articles and case studies that are peer-reviewed. It includes scientific short communications as well as a literature review with annotated articles that inform the reader on new developments in the various disciplines concerned and hence allow for a sound overview on the latest results in radiooncology research. Founded in 1912, Strahlentherapie und Onkologie is the oldest oncological journal in the world. Today, contributions are published in English and German. All articles have English summaries and legends. The journal is the official publication of several scientific radiooncological societies and publishes the relevant communications of these societies.